LPS-induced systemic inflammation reveals an immunomodulatory role for the prion protein at the blood-brain interface

J Neuroinflammation. 2017 May 22;14(1):106. doi: 10.1186/s12974-017-0879-5.

Abstract

Background: The cellular prion protein (PrPC) is an evolutionary conserved protein abundantly expressed not only in the central nervous system but also peripherally including the immune system. A line of Norwegian dairy goats naturally devoid of PrPC (PRNP Ter/Ter) provides a novel model for studying PrPC physiology.

Methods: In order to explore putative roles for PrPC in acute inflammatory responses, we performed a lipopolysaccharide (LPS, Escherichia coli O26:B6) challenge of 16 goats (8 PRNP +/+ and 8 PRNP Ter/Ter) and included 10 saline-treated controls (5 of each PRNP genotype). Clinical examinations were performed continuously, and blood samples were collected throughout the trial. Genome-wide transcription profiles of the choroid plexus, which is at the blood-brain interface, and the hippocampus were analyzed by RNA sequencing, and the same tissues were histologically evaluated.

Results: All LPS-treated goats displayed clinical signs of sickness behavior, which were of significantly (p < 0.01) longer duration in animals without PrPC. In the choroid plexus, a substantial alteration of the transcriptome and activation of Iba1-positive cells were observed. This response included genotype-dependent differential expression of several genes associated with the immune response, such as ISG15, CXCL12, CXCL14, and acute phase proteins, among others. Activation of cytokine-responsive genes was skewed towards a more profound type I interferon response, and a less obvious type II response, in PrPC-deficient goats. The magnitude of gene expression in response to LPS was smaller in the hippocampus than in the choroid plexus. Resting state expression profiles revealed a few differences between the PRNP genotypes.

Conclusions: Our data suggest that PrPC acts as a modulator of certain pathways of innate immunity signaling, particularly downstream of interferons, and probably contributes to protection of vulnerable tissues against inflammatory damage.

Keywords: Cellular prion protein; Choroid plexus; Hippocampus; Innate immunity; Lipopolysaccharide (LPS); Sickness behavior; Systemic inflammation; Transcriptome.

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • Brain / metabolism*
  • Calcium-Binding Proteins
  • Choroid Plexus / metabolism
  • Choroid Plexus / pathology
  • Chromatin Immunoprecipitation
  • Cytokines / metabolism
  • DNA-Binding Proteins / metabolism
  • Disease Models, Animal
  • Gene Expression Profiling
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Gene Ontology
  • Genotype
  • Goats
  • Illness Behavior / drug effects
  • Illness Behavior / physiology
  • Immunity, Innate / drug effects
  • Inflammation / blood*
  • Inflammation / chemically induced
  • Inflammation / immunology*
  • Inflammation / pathology*
  • Lipopolysaccharides / toxicity
  • Microfilament Proteins
  • Prion Proteins / blood
  • Prion Proteins / genetics
  • Prion Proteins / metabolism*
  • RNA, Messenger / metabolism
  • Time Factors

Substances

  • AIF1 protein, human
  • Calcium-Binding Proteins
  • Cytokines
  • DNA-Binding Proteins
  • Lipopolysaccharides
  • Microfilament Proteins
  • Prion Proteins
  • RNA, Messenger